Fulcrum Therapeutics Inc (FULC)
6.40
-0.09
(-1.39%)
USD |
NASDAQ |
Jun 20, 16:00
6.385
-0.02
(-0.23%)
After-Hours: 20:00
Fulcrum Therapeutics Price: 6.40 for June 20, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 20, 2024 | 6.44 | 6.49 | 6.27 | 6.40 | 1.033M |
| Jun 18, 2024 | 7.00 | 7.00 | 6.48 | 6.49 | 682210.0 |
| Jun 17, 2024 | 7.38 | 7.48 | 6.91 | 7.00 | 939834.0 |
| Jun 14, 2024 | 7.78 | 7.835 | 7.42 | 7.45 | 281458.0 |
| Jun 13, 2024 | 7.69 | 7.96 | 7.56 | 7.80 | 540682.0 |
| Jun 12, 2024 | 7.60 | 7.90 | 7.35 | 7.71 | 951838.0 |
| Jun 11, 2024 | 8.04 | 8.31 | 7.40 | 7.40 | 999125.0 |
| Jun 10, 2024 | 8.22 | 8.43 | 8.00 | 8.16 | 521908.0 |
| Jun 07, 2024 | 8.26 | 8.41 | 8.115 | 8.29 | 260870.0 |
| Jun 06, 2024 | 8.69 | 8.69 | 8.205 | 8.37 | 334212.0 |
| Jun 05, 2024 | 8.16 | 8.67 | 8.14 | 8.65 | 311769.0 |
| Jun 04, 2024 | 8.18 | 8.26 | 7.95 | 8.14 | 498903.0 |
| Jun 03, 2024 | 8.04 | 8.44 | 8.01 | 8.18 | 928002.0 |
| May 31, 2024 | 7.76 | 8.00 | 7.71 | 7.85 | 365770.0 |
| May 30, 2024 | 7.87 | 7.946 | 7.53 | 7.65 | 340468.0 |
| May 29, 2024 | 7.72 | 7.85 | 7.52 | 7.77 | 473581.0 |
| May 28, 2024 | 7.77 | 8.12 | 7.51 | 7.74 | 1.021M |
| May 24, 2024 | 7.43 | 7.51 | 7.20 | 7.21 | 305764.0 |
| May 23, 2024 | 7.73 | 7.735 | 7.32 | 7.42 | 379235.0 |
| May 22, 2024 | 7.66 | 7.86 | 7.628 | 7.71 | 266404.0 |
| May 21, 2024 | 7.61 | 7.78 | 7.41 | 7.64 | 570501.0 |
| May 20, 2024 | 7.76 | 8.01 | 7.69 | 7.70 | 451865.0 |
| May 17, 2024 | 7.75 | 7.75 | 7.45 | 7.55 | 480460.0 |
| May 16, 2024 | 8.32 | 8.32 | 7.74 | 7.795 | 545804.0 |
| May 15, 2024 | 7.97 | 8.76 | 7.97 | 8.25 | 1.029M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.26
Minimum
Apr 12 2023
30.97
Maximum
Sep 20 2021
10.62
Average
9.605
Median
Price Benchmarks
| Bristol-Myers Squibb Co | 41.04 |
| Moderna Inc | 134.37 |
| NovaBay Pharmaceuticals Inc | 2.28 |
| Palatin Technologies Inc | 1.88 |
| iBio Inc | 2.14 |
Price Related Metrics
| PS Ratio | 140.83 |
| Price to Book Value | 1.858 |
| Earnings Yield | -25.06% |
| Market Cap | 396.85M |